No Data
Agios Pharmaceuticals Down Over 6%, on Pace for Largest Percent Decrease Since September 2022 -- Data Talk
This HP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Micron To $150? Here Are 10 Top Analyst Forecasts For Friday
Leerink Partners Downgrades Agios Pharmaceuticals(AGIO.US) to Hold Rating, Cuts Target Price to $56
Agios Pharmaceuticals Downgraded to Market Perform From Outperform at Leerink
Express News | Agios Pharmaceuticals Inc : Leerink Partners Cuts to Market Perform From Outperform; Cuts Target Price to $56 From $60